Triazole oxytocin antagonists: Identification of an aryloxyazetidine replacement for a biaryl substituent

65Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A series of aryloxyazetidines, aryloxypyrrolidines and aryloxypiperidines were designed based on structural overlap with previously reported arylpyrazine Oxytocin antagonists. Similarly high levels of Oxytocin antagonism were achievable in these new series. Several aryloxyazetidines also showed high levels of selectivity, with one compound, 25, displaying promising in vivo pharmacokinetics and significantly improved aqueous solubility over related compounds containing a biaryl substituent. © 2009 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Brown, A., Brown, T. B., Calabrese, A., Ellis, D., Puhalo, N., Ralph, M., & Watson, L. (2010). Triazole oxytocin antagonists: Identification of an aryloxyazetidine replacement for a biaryl substituent. Bioorganic and Medicinal Chemistry Letters, 20(2), 516–520. https://doi.org/10.1016/j.bmcl.2009.11.097

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free